Theranica

Theranica company information, Employees & Contact Information

Explore related pages

Related company profiles:

Theranica is a neuromodulation therapeutics company dedicated to creating effective, safe, affordable, and low-side-effect therapies for idiopathic pain conditions. Our initial focus is on migraine, one of the most common neurologic disorders affecting over 1 billion people, with a high prevalence and morbidity, especially among adolescents and females. The company’s award-winning flagship Nerivio® REN wearable is changing the game for migraine sufferers, especially the 100 million adolescents facing this complex and non-curable disease. Nerivio is the first and only REN wearable that harnesses the natural power of the brain to shut off migraine symptoms without the use of drugs. With early intervention being key, Nerivio offers a safe and side-effect-free alternative, empowering adolescents to take control of their health and providing a foundation for complete migraine care as they transition into adulthood. Theranica is a neuromodulation therapeutics company dedicated to creating effective, safe, affordable, low-side-effect therapies for idiopathic pain conditions. The Nerivio REN wearable is FDA-cleared and CE-marked for the acute and/or preventive treatment of migraine with or without aura in people 8 years of age or older. It has been used in more than 650,000 migraine treatments in the US, including by adolescents and veterans living with migraine. Learn more by visiting our websites, theranica.com, and nerivio.com.

Company Details

Employees
88
Founded
-
Address
100 Somerset Corporate Blvd,
Phone
+972-72-390-9762
Email
nf****@****ica.com
Industry
Medical Equipment Manufacturing
NAICS
Medical Equipment and Supplies Manufacturing
Surgical and Medical Instrument Manufacturing
Surgical Appliance and Supplies Manufacturing
Dental Equipment and Supplies Manufacturing
Ophthalmic Goods Manufacturing
Dental Laboratories
HQ
Bridgewater, New Jersey
Looking for a particular Theranica employee's phone or email?

Theranica Questions

News

Theranica's Nerivio® REN Wearable Validated in Landmark 55,000-Patient Study Published in Cephalalgia - PR Newswire

Theranica's Nerivio® REN Wearable Validated in Landmark 55,000-Patient Study Published in Cephalalgia PR Newswire

Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment - BioSpace

Theranica to Present Three Real-World Evidence Studies at AHS Scientific Meeting Highlighting the Impact of the Nerivio® REN Wearable on Migraine Treatment BioSpace

Theranica Brings First-in-Class, Drug-Free Migraine Care to the Forefront at CNS 2025 with Product Theater and New Real-World Evidence - PR Newswire

Theranica Brings First-in-Class, Drug-Free Migraine Care to the Forefront at CNS 2025 with Product Theater and New Real-World Evidence PR Newswire

Pier 88 Health and Theranica Announce China NMPA Approval of the Nerivio® REN wearable for Acute Treatment of Migraine - PR Newswire

Pier 88 Health and Theranica Announce China NMPA Approval of the Nerivio® REN wearable for Acute Treatment of Migraine PR Newswire

Nerivio Device Cleared for Use in Patients With Chronic Migraine - Medical Professionals Reference

Nerivio Device Cleared for Use in Patients With Chronic Migraine Medical Professionals Reference

Theranica Announces Coverage Policy from the Second Largest - GlobeNewswire

Theranica Announces Coverage Policy from the Second Largest GlobeNewswire

Theranica announces positive results from clinical trial for migraine treatment device - Healio

Theranica announces positive results from clinical trial for migraine treatment device Healio

FDA Approves Theranica's Nerivio for Preventive Treatment of Migraine - NeurologyLive

FDA Approves Theranica's Nerivio for Preventive Treatment of Migraine NeurologyLive

Alon Ironi, CEO, Theranica, Talks a Safe and Effective Treatment Option for Migraine - Docwire News

Alon Ironi, CEO, Theranica, Talks a Safe and Effective Treatment Option for Migraine Docwire News

Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine - Frontiers

Real-World Analysis of Remote Electrical Neuromodulation (REN) for the Acute Treatment of Migraine Frontiers

Theranica Advances Migraine Care in 2024 Supported by New Research, an Expanded Indication, a new Chief Medical Officer, and Broader Insurance Coverage - PR Newswire

Theranica Advances Migraine Care in 2024 Supported by New Research, an Expanded Indication, a new Chief Medical Officer, and Broader Insurance Coverage PR Newswire

FDA Expands the Age Indication for Nerivio® as the First-and-Only REN Wearable for Migraine Treatment for Children Aged Eight and Above - PR Newswire

FDA Expands the Age Indication for Nerivio® as the First-and-Only REN Wearable for Migraine Treatment for Children Aged Eight and Above PR Newswire

Theranica's REN Wearable Becomes the First Ever Non-Pharmacological Migraine Treatment to Receive Commercial Coverage in the USA - PR Newswire

Theranica's REN Wearable Becomes the First Ever Non-Pharmacological Migraine Treatment to Receive Commercial Coverage in the USA PR Newswire

Theranica Enters Into Agreement With Dr. Reddy's for Commercializing Nerivio® in Europe - PR Newswire

Theranica Enters Into Agreement With Dr. Reddy's for Commercializing Nerivio® in Europe PR Newswire

Theranica's Nerivio® Cleared by FDA for Preventive Treatment of Migraine - PR Newswire

Theranica's Nerivio® Cleared by FDA for Preventive Treatment of Migraine PR Newswire

FDA Approves Theranica's Nerivio® for Acute Treatment of Migraine in Adolescents - PR Newswire

FDA Approves Theranica's Nerivio® for Acute Treatment of Migraine in Adolescents PR Newswire

More States Join the Movement: The Nerivio® REN Wearable Now Covered by Arizona, New Jersey, Ohio, and Virginia Medicaid Programs - PR Newswire

More States Join the Movement: The Nerivio® REN Wearable Now Covered by Arizona, New Jersey, Ohio, and Virginia Medicaid Programs PR Newswire

Theranica Expands Accessibility of Nerivio™ to U.S. Migraine Patients Via Partnership With Telemedicine Platform, Cove - PR Newswire

Theranica Expands Accessibility of Nerivio™ to U.S. Migraine Patients Via Partnership With Telemedicine Platform, Cove PR Newswire

Using Nerivio® for Migraine Prevention Results in Significant Clinical and Cost-Saving Benefits for Patients, Insurers, and Employers, According to a New Health Economics Study - PR Newswire

Using Nerivio® for Migraine Prevention Results in Significant Clinical and Cost-Saving Benefits for Patients, Insurers, and Employers, According to a New Health Economics Study PR Newswire

Clinical Study Evaluated Safety of Using Nerivio® for Treating Migraine in Pregnant Women - PR Newswire

Clinical Study Evaluated Safety of Using Nerivio® for Treating Migraine in Pregnant Women PR Newswire

Theranica receives FDA 510(k) for migraine prevention device - Mobi Health News

Theranica receives FDA 510(k) for migraine prevention device Mobi Health News

Theranica eyes EU launch with updated CE mark for migraine-easing wearable - Fierce Biotech

Theranica eyes EU launch with updated CE mark for migraine-easing wearable Fierce Biotech

Israeli startup’s migraine solution wins MedTech Breakthrough Award - www.israelhayom.com

Israeli startup’s migraine solution wins MedTech Breakthrough Award www.israelhayom.com

FDA expands clearance of Theranica's neuromodulation armband for migraine - Fierce Biotech

FDA expands clearance of Theranica's neuromodulation armband for migraine Fierce Biotech

Theranica raises $45M for migraine digital therapeutic - Mobi Health News

Theranica raises $45M for migraine digital therapeutic Mobi Health News

Theranica ropes in $45M for smartphone-connected migraine modulation armband - Fierce Biotech

Theranica ropes in $45M for smartphone-connected migraine modulation armband Fierce Biotech

Theranica aims to stretch FDA nod with study of neuromodulation device as preventive migraine treatment - Fierce Biotech

Theranica aims to stretch FDA nod with study of neuromodulation device as preventive migraine treatment Fierce Biotech

See the 22-slide presentation an Israeli startup used to raise $45 million for an easier way to treat migraines - businessinsider.com

See the 22-slide presentation an Israeli startup used to raise $45 million for an easier way to treat migraines businessinsider.com

Theranica lands VA contract for migraine device - Medical Design & Outsourcing

Theranica lands VA contract for migraine device Medical Design & Outsourcing

Israeli startup Theranica, maker of migraine-zapping device, nabs $45m investment - The Times of Israel

Israeli startup Theranica, maker of migraine-zapping device, nabs $45m investment The Times of Israel

Theranica’s Nerivio gets FDA nod for adolescent migraines - BioWorld MedTech

Theranica’s Nerivio gets FDA nod for adolescent migraines BioWorld MedTech

Can an electronic patch reduce the pain of migraines? - Unpacked

Can an electronic patch reduce the pain of migraines? Unpacked

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment - NTB Kommunikasjon

Dr. Reddy's subsidiary betapharm, and Theranica launch Nerivio® in Germany to provide patients with drug-free migraine treatment NTB Kommunikasjon

Theranica and Dr. Reddy's bring Nerivio to millions of people with migraine in India - BioSpectrum India

Theranica and Dr. Reddy's bring Nerivio to millions of people with migraine in India BioSpectrum India

Top Theranica Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant